FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

24088311000001106: Invokana 300mg tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78579601000001114 Invokana 300mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106048001000001119 Invokana 300mg tablets (Napp Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Invokana 300mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Is a Canagliflozin 300mg tablets true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Canagliflozin hemihydrate false Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Canagliflozin false Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Is a Invokana true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has active ingredient Canagliflozin true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Canagliflozin hemihydrate true Inferred relationship Existential restriction modifier
Invokana 300mg tablets (Janssen-Cilag Ltd) Has basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Invokana 300mg tablets (Janssen-Cilag Ltd) 30 tablet 3 x 10 tablets Has AMP True Invokana 300mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start